BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27683064)

  • 1. PTHrP-Derived Peptides Restore Bone Mass and Strength in Diabetic Mice: Additive Effect of Mechanical Loading.
    Maycas M; McAndrews KA; Sato AY; Pellegrini GG; Brown DM; Allen MR; Plotkin LI; Gortazar AR; Esbrit P; Bellido T
    J Bone Miner Res; 2017 Mar; 32(3):486-497. PubMed ID: 27683064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
    Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
    J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor.
    Delgado-Calle J; Tu X; Pacheco-Costa R; McAndrews K; Edwards R; Pellegrini GG; Kuhlenschmidt K; Olivos N; Robling A; Peacock M; Plotkin LI; Bellido T
    J Bone Miner Res; 2017 Mar; 32(3):522-535. PubMed ID: 27704638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine and Paracrine Regulation of the Murine Skeleton by Osteocyte-Derived Parathyroid Hormone-Related Protein.
    Ansari N; Ho PW; Crimeen-Irwin B; Poulton IJ; Brunt AR; Forwood MR; Divieti Pajevic P; Gooi JH; Martin TJ; Sims NA
    J Bone Miner Res; 2018 Jan; 33(1):137-153. PubMed ID: 28914969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the Parathyroid Hormone Type 1 Receptor (PTH1R) as a Mechanosensor in Osteocyte Survival.
    Maycas M; Ardura JA; de Castro LF; Bravo B; Gortázar AR; Esbrit P
    J Bone Miner Res; 2015 Jul; 30(7):1231-44. PubMed ID: 25529820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Wnt Signaling by Mechanical Loading Is Impaired in the Bone of Old Mice.
    Holguin N; Brodt MD; Silva MJ
    J Bone Miner Res; 2016 Dec; 31(12):2215-2226. PubMed ID: 27357062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
    Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
    PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
    Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
    J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation.
    Bivi N; Condon KW; Allen MR; Farlow N; Passeri G; Brun LR; Rhee Y; Bellido T; Plotkin LI
    J Bone Miner Res; 2012 Feb; 27(2):374-89. PubMed ID: 22028311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.
    Spatz JM; Wein MN; Gooi JH; Qu Y; Garr JL; Liu S; Barry KJ; Uda Y; Lai F; Dedic C; Balcells-Camps M; Kronenberg HM; Babij P; Pajevic PD
    J Biol Chem; 2015 Jul; 290(27):16744-58. PubMed ID: 25953900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.
    Tu X; Rhee Y; Condon KW; Bivi N; Allen MR; Dwyer D; Stolina M; Turner CH; Robling AG; Plotkin LI; Bellido T
    Bone; 2012 Jan; 50(1):209-17. PubMed ID: 22075208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of parathyroid hormone-related protein in the decreased osteoblast function in diabetes-related osteopenia.
    Lozano D; de Castro LF; Dapía S; Andrade-Zapata I; Manzarbeitia F; Alvarez-Arroyo MV; Gómez-Barrena E; Esbrit P
    Endocrinology; 2009 May; 150(5):2027-35. PubMed ID: 19196804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance.
    Zhao G; Huang BL; Rigueur D; Wang W; Bhoot C; Charles KR; Baek J; Mohan S; Jiang J; Lyons KM
    J Bone Miner Res; 2018 Jun; 33(6):1076-1089. PubMed ID: 29351359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice.
    Pereira M; Jeyabalan J; Jørgensen CS; Hopkinson M; Al-Jazzar A; Roux JP; Chavassieux P; Orriss IR; Cleasby ME; Chenu C
    Bone; 2015 Dec; 81():459-467. PubMed ID: 26314515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin.
    Robling AG; Niziolek PJ; Baldridge LA; Condon KW; Allen MR; Alam I; Mantila SM; Gluhak-Heinrich J; Bellido TM; Harris SE; Turner CH
    J Biol Chem; 2008 Feb; 283(9):5866-75. PubMed ID: 18089564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
    Allison H; Holdsworth G; McNamara LM
    BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of bone fragility by pulsed electromagnetic fields in type 2 diabetic KK-Ay mice involving Wnt/β-catenin signaling.
    Shao X; Yang Y; Tan Z; Ding Y; Luo E; Jing D; Cai J
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E951-E966. PubMed ID: 33719588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading.
    Spatz JM; Ellman R; Cloutier AM; Louis L; van Vliet M; Suva LJ; Dwyer D; Stolina M; Ke HZ; Bouxsein ML
    J Bone Miner Res; 2013 Apr; 28(4):865-74. PubMed ID: 23109229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
    Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.